epipole were selected as one of the five finalists in Novartis’ Biome 2019 Ophthalmology Innovation Challenge in their San Francisco Biome headquarters.
Among stiff competition from companies that presented their deeply innovative technology the six American Academy of Ophthalmology judges were unanimous in awarding epipole with the first prize of $6000. After a standing ovation one of the judges commented “Every GP in America should own your technology.”
Maybe one day they will.